Cue Biopharma, Inc. - Common Stock —— 季度现金流量表 (NASDAQ:CUE) | MetaTrader

展开完整图表完整图表

Financials

概览声明统计

每季度年度

总资产 32.19 M22.25 M40.71 M31.64 M42.21 M30.88 M 负债总额 14.69 M15.67 M22.55 M18.4 M15.78 M9.27 M 权益总额 17.5 M6.58 M18.16 M13.25 M26.43 M21.61 M 负债及股东权益总额 32.19 M22.25 M40.71 M31.64 M42.21 M30.88 M 总债务 0—2.71 M1.75 M—— 净债务 0—-24.79 M-16.92 M——

新闻

美国股市涨跌不一；截至收盘道琼斯工业平均指数下跌0.31%

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.31%

Morning News Wrap-Up, 5/1/26: Today’s Biggest Stock Market Stories! - TipRanks.com

What's Behind The Drop In Cue Biopharma Stock Today? - Cue Biopharma (NASDAQ:CUE)

Cue Biopharma, Inc. (CUE) Discusses CUE-401 R&D Progress and Mechanism for Autoimmune and Inflammatory Diseases - Slideshow (NASDAQ:CUE) 2026-04-09

Cue Biopharma, Inc. (CUE) Discusses CUE-401 R&D Progress and Mechanism for Autoimmune and Inflammatory Diseases Transcript

Cue BiopharmaQ1每股收益及营收超出预期

Cue Biopharma earnings beat by $0.10, revenue topped estimates

Cue Biopharma以每股0.28美元定价1000万美元公开发行

Cue Biopharma prices $10 million public offering at $0.28 per share

Cue Biopharma股价因公开发行公告暴跌

Cue Biopharma stock tumbles on public offering announcement